Onabotulinumtoxina Re-Injection for Refractory Detrusor Overactivity Using 3-4 Injection Sites: Results of a Pilot Study.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Grupos
Abstract
To determine if repeated treatment with Onabot/A in less injections points, provides similar clinical efficacy, duration, and adverse events compared with previous treatment.
Datos de la publicación
- ISSN/ISSNe:
- 0090-4295, 1527-9995
- Tipo:
- Article
- Páginas:
- 50-54
- PubMed:
- 31862326
- Factor de Impacto:
- 0,861 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Urology ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 11
Documentos
- No hay documentos
Filiaciones
Keywords
- TREATMENT BENEFIT SCALE; LONG-TERM EFFICACY; TOXIN-A BTA; URINARY-INCONTINENCE; BOTULINUM-TOXIN; DOUBLE-BLIND; SAFETY; BLADDER; VALIDATION; MANAGEMENT
Cita
MARTÍNEZ E,BONILLO MA,MORÁN E,BROSETA E,ARLANDIS S. Onabotulinumtoxina Re-Injection for Refractory Detrusor Overactivity Using 3-4 Injection Sites: Results of a Pilot Study. Urology. 2020. 137. p. 50-54. IF:2,649. (3).
Portal de investigación